Business Description
Novo Integrated Sciences Inc
NAICS : 621999
SIC : 8361
ISIN : US67011T1025
Description
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.8 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -3.16 | |||||
| Beneish M-Score | -2.52 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -28.7 | |||||
| 3-Year EBITDA Growth Rate | 26.4 | |||||
| 3-Year EPS without NRI Growth Rate | 12.9 | |||||
| 3-Year FCF Growth Rate | -4.5 | |||||
| 3-Year Book Growth Rate | -50 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.74 | |||||
| 9-Day RSI | 50.16 | |||||
| 14-Day RSI | 48.26 | |||||
| 6-1 Month Momentum % | -80.29 | |||||
| 12-1 Month Momentum % | -56.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.5 | |||||
| Quick Ratio | 0.41 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 46.49 | |||||
| Days Sales Outstanding | 68.24 | |||||
| Days Payable | 116.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -88.7 | |||||
| Shareholder Yield % | 76.59 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 40.34 | |||||
| Operating Margin % | -68.69 | |||||
| Net Margin % | -88.47 | |||||
| FCF Margin % | -36.26 | |||||
| ROE % | -48.56 | |||||
| ROA % | -33.57 | |||||
| ROIC % | -26.72 | |||||
| ROC (Joel Greenblatt) % | -116.24 | |||||
| ROCE % | -32.29 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.58 | |||||
| PB Ratio | 0.37 | |||||
| EV-to-EBIT | -1.62 | |||||
| EV-to-EBITDA | -2.18 | |||||
| EV-to-Revenue | 1.06 | |||||
| EV-to-FCF | -2.93 | |||||
| Earnings Yield (Greenblatt) % | -61.73 | |||||
| FCF Yield % | -55.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NVOS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novo Integrated Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13.658 | ||
| EPS (TTM) ($) | -0.64 | ||
| Beta | -1.71 | ||
| Volatility % | 147.06 | ||
| 14-Day RSI | 48.26 | ||
| 14-Day ATR ($) | 0.077844 | ||
| 20-Day SMA ($) | 0.497898 | ||
| 12-1 Month Momentum % | -56.28 | ||
| 52-Week Range ($) | 0.43 - 5.384 | ||
| Shares Outstanding (Mil) | 19.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novo Integrated Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novo Integrated Sciences Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novo Integrated Sciences Inc Frequently Asked Questions
What is Novo Integrated Sciences Inc(NVOS)'s stock price today?
The current price of NVOS is $0.47. The 52 week high of NVOS is $5.38 and 52 week low is $0.43.
When is next earnings date of Novo Integrated Sciences Inc(NVOS)?
The next earnings date of Novo Integrated Sciences Inc(NVOS) is 2024-04-30 Est..
Does Novo Integrated Sciences Inc(NVOS) pay dividends? If so, how much?
Novo Integrated Sciences Inc(NVOS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers